B.C.G. in malignant melanoma.
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D006801:Humans; D006967:Hypersensitivity; D007111:Immunity, Cellular; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine